Capricor Therapeutics Inc Cash Flow Quality Index
Capricor Therapeutics Inc cash flow quality index. Capricor Therapeutics Inc (CAPR) has a Cash Flow Quality Index of -0.22x as of December 2017. Operating cash flow of $-2.67 Million is below net income of $12.31 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Capricor Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Capricor Therapeutics Inc (2017–2017)
Cash flow quality index of Capricor Therapeutics Inc from 2017 to 2017. Historical Cash Flow Quality Index for Capricor Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CAPR operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Capricor Therapeutics Inc Cash Flow Quality Index by Year (2017–2017)
Capricor Therapeutics Inc cash flow quality index by year from 2017 to 2017. Year-by-year earnings quality comparison for Capricor Therapeutics Inc. For the full cash flow conversion analysis, see CAPR operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -5.85x | $-14.23 Million | $2.43 Million | — |